Adrenolipoma MRI: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Adrenolipoma}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Reflist|..." |
Category |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenolipoma}} | {{Adrenolipoma}} | ||
{{CMG}} {{AE}} {{AAM}} | |||
==Overview== | |||
Abdominal [[MRI]] may be helpful in the diagnosis of adrenolipoma. | |||
==Key MRI Findings in Adrenolipoma== | |||
Key MRI findings in adrenolipoma are:<ref name="radiopaedia"> http://radiopaedia.org/articles/adrenal-myelolipoma </ref> | |||
* Hyperintense T1 phase due to fat contents | |||
* Fat suppression on T1 (FS) | |||
* Intermediate to hyperintense T2 phase, but can sometimes vary depending on contents (especially blood products) | |||
* Striking enhancement on T1 C+ (Gd) | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrine system]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Surgery]] | ||
Latest revision as of 02:37, 24 October 2017
|
Adrenolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenolipoma MRI On the Web |
|
American Roentgen Ray Society Images of Adrenolipoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Abdominal MRI may be helpful in the diagnosis of adrenolipoma.
Key MRI Findings in Adrenolipoma
Key MRI findings in adrenolipoma are:[1]
- Hyperintense T1 phase due to fat contents
- Fat suppression on T1 (FS)
- Intermediate to hyperintense T2 phase, but can sometimes vary depending on contents (especially blood products)
- Striking enhancement on T1 C+ (Gd)